Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer

Cancer Genetics and Cytogenetics

Volumn 119, Issue 1, 2000, Pages 56-61

  Menin, C ^a   Santacatterina, M ^a   Zambon, A ^a   Montagna, M ^a   Parenti, A ^a   Ruol, A ^a   D'Andrea, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ALCOHOLISM; ARTICLE; CARCINOGENESIS; CHROMOSOME 3P; CLINICAL ARTICLE; ESOPHAGUS CANCER; FEMALE; GENE DELETION; GENE TARGETING; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SQUAMOUS CELL CARCINOMA;

ACID ANHYDRIDE HYDROLASES; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEINS; RNA, MESSENGER;

EID: 0034016997     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00216-2     Document Type: Article

References (29)

1. Kabat G.C., Ng S.K., Wynder E.L. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 4:1993;123-132.
2. Mayer R.J. Overview. the changing nature of esophageal cancer Chest. 103:1993;404S-405S.
3. Blot W.J. Esophageal cancer trends and risk factors. Semin Oncol. 21:1994;403-410.
4. Attwood S.E., Smyrk T.C., DeMeester T.R., Mirvish S.S., Stein H.J., Hinder R.A. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery. 111:1992;503-510.
5. Brown L.M., Swanson C.A., Gridley G., Swanson G.M., Schoenberg J.B., Greenberg R.S., Silverman D.T., Pottern L.M., Hayes R.B., Schwartz A.G., Liff J.M., Fraumeni J.F., Hoover R.N. Adenocarcinoma of the esophagus. role of obesity and diet J Natl Cancer Inst. 87:1995;104-109.
6. Galiana C., Lozano J.C., Bancel B., Nakazawa H., Yamasaki H. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus. Mol Carcinog. 14:1995;286-293.
7. Muzeau F., Flejou J.F., Thomas G., Hamelin R. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer. 72:1997;27-30.
8. Hayashi K., Metzger R., Salonga D., Danenberg K., Leichman L.P., Fink U., Sendler A., Kelsen D., Schawrtz G.K., Groshen S., Lenz H.J., Danenberg P.V. High frequency of simultaneous loss of p16 and p16 beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene. 15:1997;1481-1488.
9. Lisitsyn N.A., Lisitsina N.M., Dalbagni G., Barker P., Sanchez C.A., Gnarra J., Linehan W.M., Reid B.J., Wigler M.H. Comparative genomic analysis of tumors. detection of DNA losses and amplification Proc Natl Acad Sci USA. 92:1995;151-155.
10. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
11. Kastury K., Baffa R., Druck T., Ohta M., Cotticelli M.G., Inoue H., Negrini M., Rugge M., Huang D., Croce C.M., Palazzo J., Huebner K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56:1996;978-983.
12. Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A., Robinson A.K., Ingram S.W., Croce C.M., Ohta M., Huebner K. Fhit, a putative tumor suppressor in humans, is a dinucleotide 5′,5′′′-P1,P3-triphosphate hydrolase. Biochemistry. 35:1996;11529-11535.
13. Siprashvili Z., Sozzi G., Barnes L.D., McCue P., Robinson A.K., Eryomin V., Sard L., Tagliabue E., Greco A., Fusetti L., Schwartz G., Pierotti M.A., Croce C.M., Huebner K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA. 94:1997;13771-13776.
14. Virgilio L., Shuster M., Gollin S.M., Veronese M.L., Ohta M., Huebner K., Croce C.M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA. 93:1996;9770-9775.
15. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., Croce C.M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26.
16. Yanagisawa K., Kondo M., Osada H., Uchida K., Takagi K., Masuda A., Takahashi T. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res. 56:1996;5579-5582.
17. Mao L., Fan Y.H., Lotan R., Hong W.K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res. 56:1996;5128-5131.
18. Druck T., Hadaczek P., Fu T.B., Ohta M., Siprashvili Z., Baffa R., Negrini M., Kastury K., Veronese M.L., Rosen D., Rothstein J., McCue P., Cotticelli M.G., Inoue H., Croce C.M., Huebner K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57:1997;504-512.
19. Hayashi S., Tanimoto K., Hajiro-Nakanishi K., Tsuchiya E., Kurosumi M., Higashi Y., Imai K., Suga K., Nakachi K. Abnormal FHIT transcripts in human breast carcinomas. a clinicopathological and epidemiological analysis of 61 Japanese cases Cancer Res. 57:1997;1981-1985.
20. Huebner K., Hadaczek P., Siprashvili Z., Druck T., Croce C.M. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B. Biochim Biophys Acta. 1332:1997;M65-M70.
21. Gemma A., Hagiwara K., Ke Y., Burke L.M., Khan M.A., Nagashima M., Bennett W.P., Harris C.C. FHIT mutations in human primary gastric cancer. Cancer Res. 57:1997;1435-1437.
22. Zou T.T., Lei J., Shi Y.Q., Yin J., Wang S., Souza R.F., Kong D., Shimada Y., Smolinski K.N., Greenwald B.D., Abraham J.M., Harpaz N., Meltzer S.J. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Oncogene. 15:1997;101-105.
23. Michael D., Beer D.G., Wilke C.W., Miller D.E., Glover T.W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene. 15:1997;1653-1659.
24. Yoshino K., Enomoto T., Nakamura T., Nakashima R., Wada H., Saitoh J., Noda K., Murata Y. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer. 76:1998;176-181.
25. Simon B., Bartsch D., Barth P., Prasnikar N., Munch K., Blum A., Arnold R., Goke B. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res. 58:1998;1583-1587.
26. Negrini M., Monaco C., Vorechovsky I., Ohta M., Druck T., Baffa R., Huebner K., Croce C.M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res. 56:1996;3173-3179.
27. Gleeson C.M., Sloan J.M., McGuigan J.A., Ritchie A.J., Weber J.L., Russell S.E. Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Res. 56:1996;259-263.
28. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
29. Sozzi G., Sard L., De Gregorio L., Marchetti A., Musso K., Buttitta F., Tornielli S., Pellegrini S., Veronese M.L., Manenti G., Incarbone M., Chella A., Angeletti C.A., Pastorino U., Huebner K., Bevilaqua G., Pilotti S., Croce C.M., Pierotti M.A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 57:1997;2121-2123.